Baxter receives tentative US FDA approval for Ondansetron injection (PharmaBiz)
Baxter Healthcare Corporation has received tentative approvals from the US Food and Drug Administration (FDA) for Ondansetron injection USP, including the first tentative approval for a premix version of GlaxoSmithKline's Zofran, which is used for the prevention of nausea and vomiting.

Aksys Receives FDA Warning Letter (PR Newswire via Yahoo! Finance)
Aksys , Ltd. , a pioneer in innovative dialysis systems, today announced that it received a warning letter dated June 8, 2006 from the United States Food and Drug Administration .

Baxter Receives Tentative FDA Approvals For Ondansetron Injection In Vials And Premix Containers (RedNova)
DEERFIELD, Ill., June 15 /PRNewswire-FirstCall/ -- Baxter Healthcare Corporation today announced that it has received tentative approvals from the U.S.